Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4651
iShares MSCI India Small-Cap ETF
SMIN
$735M
| $30.9K | ﹤0.01% |
400
| – | – |
2023 Q4
6 quarters
|
|
4652
TScan Therapeutics
TCRX
$21.7M
| $30.7K | ﹤0.01% |
21,178
-40,672
| -66% | -$58.8K |
2024 Q2
4 quarters
|
|
4653
Virgin Galactic
SPCE
$459M
| $30.5K | ﹤0.01% |
11,185
-37,386
| -77% | -$114K |
2022 Q1
13 quarters
|
|
4654
Lexicon Pharmaceuticals
LXRX
$810M
| $30.5K | ﹤0.01% |
32,270
-113,801
| -78% | -$73.7K |
2013 Q2
48 quarters
|
|
4655
iShares Currency Hedged MSCI Japan ETF
HEWJ
$661M
| $30.5K | ﹤0.01% |
681
| – | – |
2023 Q2
8 quarters
|
|
4656
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$35.8B
| $30.4K | ﹤0.01% |
580
| – | – |
2025 Q1
1 quarter
|
|
4657
Lipocine
LPCN
$16.9M
| $29.7K | ﹤0.01% |
+9,412
| New | +$30.5K |
2025 Q2
0 quarters
|
|
4658
Oramed Pharmaceuticals
ORMP
$187M
| $29.7K | ﹤0.01% |
13,198
| – | – |
2015 Q4
38 quarters
|
|
|
NYXH
4659
Nyxoah
NYXH
$139M
| $29.5K | ﹤0.01% |
3,943
+3,709
| +1,585% | +$25.5K |
2025 Q1
1 quarter
|
|
|
INGM
4660
Ingram Micro Holding
INGM
$6.56B
| $29.4K | ﹤0.01% |
1,412
+1,277
| +946% | +$23.8K |
2024 Q4
2 quarters
|
|
4661
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$338M
| $29.3K | ﹤0.01% |
600
| – | – |
2024 Q2
4 quarters
|
|
4662
iShares Global Clean Energy ETF
ICLN
$2.23B
| $28.5K | ﹤0.01% |
2,175
-1,814
| -45% | -$22.2K |
2020 Q1
21 quarters
|
|
4663
US GoldMining
USGO
$91.5M
| $27.9K | ﹤0.01% |
+3,407
| New | +$32.8K |
2025 Q2
0 quarters
|
|
|
XAPR
4664
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - April
XAPR
$33.9M
| $27.8K | ﹤0.01% |
791
-4,763
| -86% | -$162K |
2024 Q3
3 quarters
|
|
4665
James Hardie Industries
JHX
$14.5B
| $27.8K | ﹤0.01% |
1,032
+1,014
| +5,633% | +$24.5K |
2025 Q1
1 quarter
|
|
|
VLOSU
4666
Velos Acquisition I Corp Units
VLOSU
$278M
| $27.5K | ﹤0.01% |
2,310
| – | – |
2024 Q4
2 quarters
|
|
|
ZYXI
4667
DELISTED
Zynex
ZYXI
| $27.5K | ﹤0.01% |
10,652
-16,607
| -61% | -$37.6K |
2022 Q1
13 quarters
|
|
4668
Caribou Biosciences
CRBU
$131M
| $27.3K | ﹤0.01% |
21,688
-82,720
| -79% | -$81.4K |
2022 Q1
13 quarters
|
|
4669
First Northwest Bancorp
FNWB
$94.6M
| $27.2K | ﹤0.01% |
3,527
-973
| -22% | -$9K |
2016 Q3
35 quarters
|
|
4670
Schwab U.S Small- Cap ETF
SCHA
$22B
| $27.1K | ﹤0.01% |
1,072
| – | – |
2021 Q2
16 quarters
|
|
|
ACB
4671
Aurora Cannabis
ACB
$248M
| $26.8K | ﹤0.01% |
6,317
+3,900
| +161% | +$18.9K |
2022 Q1
13 quarters
|
|
4672
Pampa Energía
PAM
$4.09B
| $26.4K | ﹤0.01% |
+380
| New | +$28.5K |
2025 Q2
0 quarters
|
|
4673
FT Vest US Equity Deep Buffer ETF April
DAPR
$324M
| $26.2K | ﹤0.01% |
695
-3,259
| -82% | -$119K |
2024 Q3
3 quarters
|
|
4674
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.25B
| $26K | ﹤0.01% |
+150
| New | +$21.1K |
2025 Q2
0 quarters
|
|
|
DXYZ
4675
Destiny Tech100
DXYZ
$999M
| $26K | ﹤0.01% |
683
-365
| -35% | -$13.8K |
2024 Q2
4 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.